含氟药物克唑替尼的中国专利分析  

Chinese Patent Analysis of Fluorine-containing Drug Crizotinib

作　　者：周琼 蒋瑞[1] ZHOU Qiong;JIANG Rui(Patent Examination Cooperation(Tianjin)Center of the Patent Office,CNIPA,Tianjin 300304,China)

机构地区：[1]国家知识产权局专利局专利审查协作天津中心,天津300304

出　　处：《有机氟工业》2024年第1期43-48,共6页Organo-Fluorine Industry

摘　　要：通过对克唑替尼的原研专利和中国专利进行分析,对克唑替尼的知识产权状况进行梳理,有助于国内相关企业对其知识产权现状有较为全面的了解。Through the analysis of the original research patents and Chinese patents of crizotinib,the intellectual property status of crizotinib is sorted out,which is helpful for domestic enterprises to have a more comprehensive understanding of its intellectual property status.

关 键 词：专利分析 克唑替尼 含氟药物 

分 类 号：R979.1[医药卫生—药品] G255.53[医药卫生—药学]